By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Phylonix Pharmaceuticals, Inc. 

100 Inman Street
Suite 300
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-441-6700 Fax: 617-441-6766


Key Statistics

Ownership: Private

Web Site: Phylonix Pharmaceuticals, Inc.


Company News
National Institutes of Health (NIH) Grants Phylonix Phase II SBIR to Develop High-Throughput In Vivo Zebrafish Assays for Assessing Cytochrome P450 Drug Metabolism and Safety 1/7/2009 9:42:31 AM
Phylonix Pharmaceuticals, Inc. Granted Broad European Patent for Transplanting Human Cells Into Zebrafish 12/18/2007 8:58:26 AM
Phylonix Pharmaceuticals, Inc. Release: National Institutes of Health (NIH) Awards Phylonix Phase II SBIR to Develop Zebrafish Models for Eye Diseases 10/2/2007 8:51:55 AM
EPA Selects Phylonix Pharmaceuticals, Inc. to Screen Compound Library in Zebrafish 4/12/2007 10:36:22 AM
Phylonix Pharmaceuticals, Inc. Awarded National Science Foundation Phase II SBIR To Screen Industrial Chemicals For Effects On Developmental Toxicity In Zebrafish 12/12/2006 11:39:19 AM
Phylonix Pharmaceuticals, Inc. Release: Zebrafish Show Advantages In Assessing Human Cancer Cell-Induced Angiogenesis In Vivo 8/8/2006 11:16:02 AM
Phylonix Pharmaceuticals, Inc. Issued Broad U.S. Patent For Screening Angiogenic Compounds Using Zebrafish 5/10/2006 11:29:02 AM
Strategic Research Institute New Trends & Technologies Accelerating Preclinical Development Conference To Take Place Jan 24-25 In La Jolla, CA 10/19/2005 5:11:58 PM
NIH Awards Phylonix Pharmaceuticals, Inc. Phase II SBIR To Develop Zebrafish Apoptosis Drug Screening Assays10/19/2005 5:11:34 PM
Phylonix Pharmaceuticals, Inc. Granted U.S. Patent For High Throughput Drug Screening Using Zebrafish10/19/2005 5:10:38 PM